Expression of human cytochrome P450 46A1 in Escherichia coli: effects of N- and C-terminal modifications
Authors:
- Ulla AnderssonUAUlla Andersson
- Kazuo NakayamaKNKazuo Nakayama
- Ingemar BjorkhemIBIngemar Bjorkhem
- Irina A. PikulevaIPIrina A. Pikuleva
- 1 August 2004
- journal article
- research article
- Published by Elsevier in Archives of Biochemistry and Biophysics
- Vol. 428 (1) , 99-108
Abstract
No abstract availableKeywords
This publication has 20 references indexed in Scilit:
- Variants of CYP46A1 may interact with age and APOE to influence CSF A 42 levels in Alzheimer?s diseaseHuman Genetics, 2004
- Broad Substrate Specificity of Human Cytochrome P450 46A1 Which Initiates Cholesterol Degradation in the BrainBiochemistry, 2003
- Increased Brain β-Amyloid Load, Phosphorylated Tau, and Risk of Alzheimer Disease Associated With an Intronic CYP46 PolymorphismArchives of Neurology, 2003
- Polymorphism in the cholesterol 24S-hydroxylase gene is associated with Alzheimer's diseaseMolecular Psychiatry, 2002
- Genetic variation in the cholesterol 24-hydroxylase (CYP46) gene and the risk of Alzheimer's diseaseNeuroscience Letters, 2002
- Nuclear Receptors and Lipid Physiology: Opening the X-FilesScience, 2001
- Oxysterol biosynthetic enzymesBiochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids, 2000
- Engineering Microsomal Cytochrome P450 2C5 to Be a Soluble, Monomeric EnzymeJournal of Biological Chemistry, 2000
- cDNA cloning of cholesterol 24-hydroxylase, a mediator of cholesterol homeostasis in the brainProceedings of the National Academy of Sciences, 1999
- Cholesterol homeostasis in human brain: evidence for an age-dependent flux of 24S-hydroxycholesterol from the brain into the circulation.Proceedings of the National Academy of Sciences, 1996